Inventor · disambiguated record
Anders Krarup
Also filed as: KRARUP ANDERS
7 granted patents·2 pending applications·29 citations·filing 2014–2022
81Inventor score
Files withJANSSEN VACCINES & PREVENTION BV9
Top patents by PatentIndex Score
9 records- 0193US10899800B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted Jan 26, 2021·12 cites·38 claims
- 0291US11155583B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2017·Granted Oct 26, 2021·7 cites·19 claims
- 0385US10369214B2Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·5 cites·51 claims
- 0481US10294279B2Stabilized soluble pre-fusion RSV F polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2014·Granted May 21, 2019·5 cites·22 claims
- 0573US2023265127A1Stabilized soluble pre-fusion rsv f polypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2022·Application pending·0 cites
- 0671US12234264B2Stabilized soluble pre-fusion RSV F proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 25, 2025·0 cites·8 claims
- 0771US11896663B2Immunodeficiency virus type 1 (HIV-1) mutant envelope proteinsJANSSEN VACCINES & PREVENTION BV·Filed 2021·Granted Feb 13, 2024·0 cites·6 claims
- 0870US10973907B2Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigensJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Apr 13, 2021·0 cites·15 claims
- 0965US2021101940A1Stabilized Soluble Pre-Fusion RSV F PolypeptidesJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anders Krarup files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →